Abstract:Atherosclerotic plaque destabilization and rupture leads to acute coronary syndromes which cause serious damage to human health worldwide. However, there is currently a lack of efficient therapeutic methods. Mammalian target of rapamycin (mTOR) has been suggested to be involved in the development of atherosclerotic plaques and serves as a therapeutic target. The present study was performed to determine whether RNA interference (RNAi) of mTOR in vivo by LV-mediated small hairpin RNA (shRNA) was capable of inhibiting the progression of atherosclerotic plaques. LV-mediated shRNA against mTOR (LV-shmTOR) was designed and obtained. Male apolipoprotein E-deficient mice were fed a high-fat diet and a constrictive collar was placed around the right carotid arteries of these mice to induce plaque formation. Eight weeks after surgery, mice were randomly divided into the mTOR RNA interference (LV-shmTOR) group, receiving treatment with LV-mTOR-shRNA; the LV-shCON group, receiving treatment with LV-non-specific-shRNA; and the control group, receiving treatment with phosphate-buffered saline. Following transfection, the mice were sacrificed to evaluate the effects of mTOR expression silencing on atherosclerosis. Transfection of LV-mTOR-shRNA markedly inhibited the mRNA and protein expression levels. Knockdown of mTOR ameliorated dysregulated blood lipid metabolism and stabilized aortic atherosclerotic plaques by decreasing the plaque area and increasing the fibrous cap and cap-to-core ratio. Furthermore, macrophages were decreased by silencing mTOR in atherosclerotic plaques. In addition, western blot analysis revealed that the knockdown of mTOR increased autophagy-related protein 13 (Atg13) dephosphorylation and light chain 3-I/light chain 3-II (LC3-I/LC3-II) ratios, both of which were associated with a high activity of autophagy, suggesting an increase of autophagy in atherosclerotic plaques. Moreover, genes including matrix metalloproteinase 2, monocyte chemoattractant protein 1 and tissue factor, which promote plaque instability, were downregulated by silencing mTOR. These results demonstrate that LV-mediated mTOR silencing by RNAi treatment induces macrophage autophagy and is a potential strategy for the treatment of atherosclerotic plaques.

Vascular Electrical Stimulation with Wireless, Battery‐Free, and Fully Implantable Features Reduces Atherosclerotic Plaque Formation Through Sirt1‐Mediated Autophagy (Small 40/2023)

Vascular Electrical Stimulation with Wireless, Battery‐Free, and Fully Implantable Features Reduces Atherosclerotic Plaque Formation Through Sirt1‐Mediated Autophagy

Inhibited Atherosclerotic Plaque Formation by Local Administration of Magnetically Labeled Endothelial Progenitor Cells (epcs) in a Rabbit Model.

Adipose stromal cell and sarpogrelate orchestrate the recovery of inflammation-induced angiogenesis in aged hindlimb ischemic mice.

Effect of Endostatin Gene Transfer Mediated by Electric Pulses into Skeletal Muscles on Development of Atherosclerotic Plaques in Mice

[Effect of spinal cord stimulation on myocardial ischemia/infarction].

An RF device for effective thermal treatment of atherosclerosis.

Sonodynamic Therapy Suppresses Neovascularization in Atherosclerotic Plaques via Macrophage Apoptosis-Induced Endothelial Cell Apoptosis

Targeted Delivery of Platelet Membrane Modified Extracellular Vesicles into Atherosclerotic Plaque to Regress Atherosclerosis

A Multi-Dimensional Analysis of a Novel Approach for Wireless Stimulation.

Fully implantable wireless batteryless vascular electronics with printed soft sensors for multiplex sensing of hemodynamics

LIFU-unlocked endogenous H 2 S generation for enhancing atherosclerosis-specific gas-enzymatic therapy

Rapid inhibition of atherosclerotic plaque progression by sonodynamic therapy

LIFU-unlocked endogenous H2S generation for enhancing atherosclerosis-specific gas-enzymatic therapy

Knockdown Of Mtor By Lentivirus-Mediated Rna Interference Suppresses Atherosclerosis And Stabilizes Plaques Via A Decrease Of Macrophages By Autophagy In Apolipoprotein E-Deficient Mice

Engineering extracellular vesicles derived from endothelial cells sheared by laminar flow for anti-atherosclerotic therapy through reprogramming macrophage

In Vivo Intravascular Pacing Using a Wireless Microscale Stimulator

Novel Metal-Free Nanozyme for Targeted Imaging and Inhibition of Atherosclerosis via Macrophage Autophagy Activation to Prevent Vulnerable Plaque Formation and Rupture

Moderate Autophagy Inhibits Vascular Smooth Muscle Cell Senescence to Stabilize Progressed Atherosclerotic Plaque via the mTORC1/ULK1/ATG13 Signal Pathway

Extracellular vesicles produced by human-induced pluripotent stem cell-derived endothelial cells can prevent arterial stenosis in mice via autophagy regulation

Platelet-derived extracellular vesicles to target plaque inflammation for effective anti-atherosclerotic therapy